Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-05
DOI
10.1038/s41417-018-0032-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy
- (2018) Xinyi Wang et al. CURRENT CANCER DRUG TARGETS
- Ecrg4 peptide is the ligand of multiple scavenger receptors
- (2018) Tetsuo Moriguchi et al. Scientific Reports
- MicroRNAs as therapeutic targets for the treatment of diabetes mellitus and its complications
- (2017) Romano Regazzi EXPERT OPINION ON THERAPEUTIC TARGETS
- Engineering Exosomes for Cancer Therapy
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Melanoma cell–derived exosomes promote epithelial–mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment
- (2016) Deyi Xiao et al. CANCER LETTERS
- LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
- (2016) Gerardo Botti et al. CURRENT DRUG TARGETS
- Exosome-like vesicles released from lipid-induced insulin-resistant muscles modulate gene expression and proliferation of beta recipient cells in mice
- (2016) Audrey Jalabert et al. DIABETOLOGIA
- Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases
- (2016) Dang Xitong et al. GENE
- Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models
- (2016) Mohamad Hadla et al. Nanomedicine
- ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo
- (2016) Zhengxu Cai et al. TUMOR BIOLOGY
- Soluble purified recombinant C2ORF40 protein inhibits tumor cell growth in vivo by decreasing telomerase activity in esophageal squamous cell carcinoma
- (2016) Linwei Li et al. Oncology Letters
- Ecrg4 contributes to the anti-glioma immunosurveillance through type-I interferon signaling
- (2016) Tetsuo Moriguchi et al. OncoImmunology
- Exosomes as drug delivery vehicles for Parkinson's disease therapy
- (2015) Matthew J. Haney et al. JOURNAL OF CONTROLLED RELEASE
- Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery
- (2015) Tek N. Lamichhane et al. MOLECULAR PHARMACEUTICS
- miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
- (2015) Keith O’Brien et al. Oncotarget
- The Clinical Relevance of Long Non-Coding RNAs in Cancer
- (2015) Andreia Silva et al. Cancers
- Thrombin-processed Ecrg4 recruits myeloid cells and induces antitumorigenic inflammation
- (2014) Jisook Lee et al. NEURO-ONCOLOGY
- Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3′-untranslated regions
- (2013) Arsen O Batagov et al. Biology Direct
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
- (2013) Yanhua Tian et al. BIOMATERIALS
- Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles
- (2013) Sander A.A. Kooijmans et al. JOURNAL OF CONTROLLED RELEASE
- ECRG4 inhibits growth and invasiveness of squamous cell carcinoma of the head and neck in vitro and in vivo
- (2013) TING XU et al. Oncology Letters
- Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
- (2013) Jessian L Munoz et al. Molecular Therapy-Nucleic Acids
- Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4
- (2012) Xitong Dang et al. CELL AND TISSUE RESEARCH
- Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages
- (2011) Cecilia Lässer et al. Journal of Translational Medicine
- Processing of Proaugurin Is Required to Suppress Proliferation of Tumor Cell Lines
- (2011) Akihiko Ozawa et al. MOLECULAR ENDOCRINOLOGY
- Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion
- (2010) Wei Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
- (2009) Silke Götze et al. BMC CANCER
- Hypermethylation of Genes for Diagnosis and Risk Stratification of Prostate Cancer
- (2009) Donkena Krishna Vanaja et al. CANCER INVESTIGATION
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growthin vitroandin vivo
- (2009) Lin-Wei Li et al. INTERNATIONAL JOURNAL OF CANCER
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started